Insilico drug repurposing using FDA approved drugs against Membrane protein of SARS-CoV-2

The novel coronavirus (SARS-CoV-2) outbreak has started taking away the millions of lives worldwide. Identification of known and approved drugs against novel coronavirus disease (COVID-19) seems to be an urgent need for the repurposing of the existing drugs. So, here we examined a safe strategy of u...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Pharm Sci
Hauptverfasser: Peele, K.Abraham, Kumar, Vikas, Parate, Shraddha, Srirama, Krupanidhi, Lee, Keun Woo, Venkateswarulu, T.C.
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Pharmacists Association®. Published by Elsevier Inc. 2021
Schlagworte:
Rapid Communication
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7934671/
https://ncbi.nlm.nih.gov/pubmed/33684397
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.xphs.2021.03.004
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge